These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30782220)

  • 61. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
    González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
    BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Parenteral iron therapy in chronic kidney disease or chronic heart failure].
    Eisenga MF; Diepenbroek A; Swinkels DW; Bakker SJ; van der Meer P; Gaillard CA
    Ned Tijdschr Geneeskd; 2015; 159():A8769. PubMed ID: 26374719
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. What Should We Target in Heart Failure: Hemoglobin or Iron?
    Hawwa N; Tang WH
    Rev Esp Cardiol (Engl Ed); 2016 Sep; 69(9):811-2. PubMed ID: 27402492
    [No Abstract]   [Full Text] [Related]  

  • 66. Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.
    De Vecchis R; Cesaro A; Ariano C
    Minerva Cardioangiol; 2018 Oct; 66(5):659-670. PubMed ID: 28398017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High prevalence of iron deficiency in patients with acute decompensated heart failure.
    Cohen-Solal A; Damy T; Terbah M; Kerebel S; Baguet JP; Hanon O; Zannad F; Laperche T; Leclercq C; Concas V; Duvillié L; Darné B; Anker S; Mebazaa A
    Eur J Heart Fail; 2014 Sep; 16(9):984-91. PubMed ID: 25065368
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure.
    Kurz K; Lanser L; Seifert M; Kocher F; Pölzl G; Weiss G
    ESC Heart Fail; 2020 Aug; 7(4):1880-1890. PubMed ID: 32458571
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure.
    Moliner P; Jankowska EA; van Veldhuisen DJ; Farre N; Rozentryt P; Enjuanes C; Polonski L; Meroño O; Voors AA; Ponikowski P; Van der Meer P; Comin-Colet J
    Int J Cardiol; 2017 Sep; 243():360-366. PubMed ID: 28511855
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.
    González-Costello J; Comín-Colet J
    Eur J Heart Fail; 2010 Nov; 12(11):1159-62. PubMed ID: 20855375
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Iron deficiency and cardiovascular disease.
    Savarese G; von Haehling S; Butler J; Cleland JGF; Ponikowski P; Anker SD
    Eur Heart J; 2023 Jan; 44(1):14-27. PubMed ID: 36282723
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists.
    Cohen-Solal A; Leclercq C; Mebazaa A; De Groote P; Damy T; Isnard R; Galinier M
    Arch Cardiovasc Dis; 2014 Oct; 107(10):563-71. PubMed ID: 25239645
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Why and how to treat iron deficiency in heart failure ?].
    Tridetti J; Nguyen Trung ML; Ancion A; Oury C; Moonen M; Lancellotti P
    Rev Med Liege; 2020 Jan; 75(1):23-28. PubMed ID: 31920040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.
    Jelani QU; Katz SD
    Cardiol Rev; 2010; 18(5):240-50. PubMed ID: 20699672
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group.
    Pezel T; Audureau E; Mansourati J; Baudry G; Ben Driss A; Durup F; Fertin M; Godreuil C; Jeanneteau J; Kloeckner M; Koukoui F; Kesri-Tartière L; Laperche T; Roubille F; Cohen-Solal A; Damy T
    ESC Heart Fail; 2021 Apr; 8(2):1509-1521. PubMed ID: 33619905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rationale and design of a randomised trial of intravenous iron in patients with heart failure.
    Kalra PR; Cleland JG; Petrie MC; Ahmed FZ; Foley PW; Kalra PA; Lang NN; Lane RE; Macdougall IC; Pellicori P; Pope MTB; Robertson M; Squire IB; Thomson EA; Ford I
    Heart; 2022 Nov; 108(24):1979-1985. PubMed ID: 35948408
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation.
    Paolillo S; Scardovi AB; Campodonico J
    Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):27-34. PubMed ID: 33238738
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Beale AL; Warren JL; Roberts N; Meyer P; Townsend NP; Kaye D
    Open Heart; 2019; 6(1):e001012. PubMed ID: 31168385
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Iron deficiency as therapeutic target in heart failure: a translational approach.
    Bakogiannis C; Briasoulis A; Mouselimis D; Tsarouchas A; Papageorgiou N; Papadopoulos C; Fragakis N; Vassilikos V
    Heart Fail Rev; 2020 Mar; 25(2):173-182. PubMed ID: 31230175
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Iron deficiency in patients of heart failure with reduced ejection fraction.
    Singh B; Bajaj N; Singh P; Kumar Ghosh A; Anathakrishnan R; Singh N
    Med J Armed Forces India; 2022 Oct; 78(4):463-468. PubMed ID: 36267507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.